136 related articles for article (PubMed ID: 9345357)
1. The role of surgical cytoreduction in Stage IV endometrial carcinoma.
Chi DS; Welshinger M; Venkatraman ES; Barakat RR
Gynecol Oncol; 1997 Oct; 67(1):56-60. PubMed ID: 9345357
[TBL] [Abstract][Full Text] [Related]
2. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
3. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival.
Lambrou NC; Gómez-Marín O; Mirhashemi R; Beach H; Salom E; Almeida-Parra Z; Peñalver M
Gynecol Oncol; 2004 Jun; 93(3):653-8. PubMed ID: 15196860
[TBL] [Abstract][Full Text] [Related]
4. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
Bristow RE; Duska LR; Montz FJ
Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657
[TBL] [Abstract][Full Text] [Related]
5. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.
Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ
Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785
[TBL] [Abstract][Full Text] [Related]
6. [Endometrial adenocarcinoma treated with combined radiotherapy and surgery: 437 cases].
Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Ginesty C; Ganansia V; Jamali M; Milliez J; Blondon J; Schlienger M
Cancer Radiother; 2001 Aug; 5(4):425-44. PubMed ID: 11521391
[TBL] [Abstract][Full Text] [Related]
7. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
8. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Chi DS; Eisenhauer EL; Lang J; Huh J; Haddad L; Abu-Rustum NR; Sonoda Y; Levine DA; Hensley M; Barakat RR
Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056
[TBL] [Abstract][Full Text] [Related]
9. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator.
Bristow RE; Montz FJ
Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412
[TBL] [Abstract][Full Text] [Related]
10. Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases.
Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM
Gynecol Oncol; 2000 Aug; 78(2):171-5. PubMed ID: 10926798
[TBL] [Abstract][Full Text] [Related]
11. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
12. Surgical stage IV endometrial carcinoma: a study of 47 cases.
Goff BA; Goodman A; Muntz HG; Fuller AF; Nikrui N; Rice LW
Gynecol Oncol; 1994 Feb; 52(2):237-40. PubMed ID: 8314145
[TBL] [Abstract][Full Text] [Related]
13. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: a retrospective multi-institutional analysis of 248 patients in Japan.
Eto T; Saito T; Kasamatsu T; Nakanishi T; Yokota H; Satoh T; Nogawa T; Yoshikawa H; Kamura T; Konishi I
Gynecol Oncol; 2012 Nov; 127(2):338-44. PubMed ID: 22910693
[TBL] [Abstract][Full Text] [Related]
15. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
16. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma.
Shih KK; Yun E; Gardner GJ; Barakat RR; Chi DS; Leitao MM
Gynecol Oncol; 2011 Sep; 122(3):608-11. PubMed ID: 21664663
[TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery.
Ueda Y; Enomoto T; Miyatake T; Egawa-Takata T; Ugaki H; Yoshino K; Fujita M; Kimura T
Ann Surg Oncol; 2010 Apr; 17(4):1111-7. PubMed ID: 20058191
[TBL] [Abstract][Full Text] [Related]
18. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma.
Thomas MB; Mariani A; Cliby WA; Keeney GL; Podratz KC; Dowdy SC
Gynecol Oncol; 2007 Nov; 107(2):190-3. PubMed ID: 17825394
[TBL] [Abstract][Full Text] [Related]
19. A multi-institutional review of outcomes of endometrial stromal sarcoma.
Leath CA; Huh WK; Hyde J; Cohn DE; Resnick KE; Taylor NP; Powell MA; Mutch DG; Bradley WH; Geller MA; Argenta PA; Gold MA
Gynecol Oncol; 2007 Jun; 105(3):630-4. PubMed ID: 17320937
[TBL] [Abstract][Full Text] [Related]
20. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
